Strata skin sciences to participate in the benchmark 12th annual discovery one-on-one investor conference

Horsham, pa., dec. 01, 2023 (globe newswire) -- strata skin sciences, inc. (nasdaq: sskn), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced that the company will be participating in the benchmark 12th annual discovery one-on-one investor conference being held in new york city on december 7, 2023. details for the event are as follows:
SSKN Ratings Summary
SSKN Quant Ranking